Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Florida Chemical Company, Inc [Member]	EOGA [Member]	SiteLark [Member]	IAL [Member]	Common Stock [Member]	Common Stock [Member] Florida Chemical Company, Inc [Member]	Common Stock [Member] EOGA [Member]	Common Stock [Member] SiteLark [Member]	Common Stock [Member] IAL [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Florida Chemical Company, Inc [Member]	Additional Paid-in Capital [Member] EOGA [Member]	Additional Paid-in Capital [Member] SiteLark [Member]	Additional Paid-in Capital [Member] IAL [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings (Accumulated Deficit) [Member]	Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2012	$ 154,730					$ 5					$ (3,701)	$ 195,485					$ (40)	$ (37,019)
Beginning balance, shares at Dec. 31, 2012						53,124,000					2,198,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)	36,178																	36,178
Foreign currency translation adjustment	(319)																(319)
Issuance cost of preferred stock an detachable warrants	(200)											(200)
Stock issued under employee stock purchase plan	824											824
Stock issued under employee stock purchase plan, shares											(44,000)
Common stock issued in payment of accrued liability	0
Stock warrants exercised	$ 323											323
Stock warrants exercised, shares	267,000					267,000
Stock options exercised	$ 4,397											4,397
Stock options exercised, shares						572,000
Restricted stock granted, shares						802,000
Restricted stock forfeited, shares											115,000
Stock granted in incentive performance plan, shares						217,000
Treasury stock purchased	$ (7,568)										$ (7,568)
Treasury stock purchased, shares	448,121										448,000
Stock surrendered for exercise of stock options	$ (3,907)										$ (3,907)
Stock surrendered for exercise of stock options, shares	237,267										237,000
Excess tax benefit related to share-based awards	$ 1,668											1,668
Stock compensation expense	10,914											10,914
Stock issued in acquisition		$ 52,712					$ 1						$ 52,711
Stock issued in acquisition, shares							3,284,000
Return of borrowed shares under share lending agreement											2,440,000
Ending balance at Dec. 31, 2013	249,752					$ 6					$ (15,176)	266,122					(359)	(841)
Ending balance, shares at Dec. 31, 2013						58,266,000					5,394,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)	53,603																	53,603
Foreign currency translation adjustment	(143)																(143)
Stock issued under employee stock purchase plan	906											906
Stock issued under employee stock purchase plan, shares											(43,000)
Common stock issued in payment of accrued liability	$ 600											600
Common stock issued in payment of accrued liability, shares	27,101					27,000
Stock warrants exercised	$ 1,545											1,545
Stock warrants exercised, shares	1,277,250					1,277,000
Stock options exercised	$ 1,660											1,660
Stock options exercised, shares	311,954					312,000
Restricted stock granted, shares	525,120					526,000
Restricted stock forfeited, shares											61,000
Treasury stock purchased	$ (6,294)										$ (6,294)
Treasury stock purchased, shares	243,005										243,000
Stock surrendered for exercise of stock options	$ (1,198)										$ (1,198)
Stock surrendered for exercise of stock options, shares	46,208										46,000
Excess tax benefit related to share-based awards	$ 3,448											3,448
Stock compensation expense	10,476											10,476
Investment in Flotek Gulf, LLC and Flotek Gulf Research, LLC	$ 351																		$ 351
Stock issued in acquisition			$ 1,894	$ 149										$ 1,894	$ 149
Stock issued in acquisition, shares	99,681							94,000	5,000
Repurchase of common stock	$ (10,395)										$ (10,395)
Repurchase of common stock, shares											621,000
Retirement of Treasury Stock						$ (1)					$ 32,568	(32,567)
Retirement of Treasury Stock, shares	(5,873,291)					(5,873,000)					(5,873,000)
Ending balance at Dec. 31, 2014	$ 306,354					$ 5					$ (495)	254,233					(502)	52,762	351
Ending balance, shares at Dec. 31, 2014						54,634,000					449,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(13,462)																	(13,462)
Foreign currency translation adjustment	(735)																(735)
Stock issued under employee stock purchase plan	879											879
Stock issued under employee stock purchase plan, shares											(77,000)
Common stock issued in payment of accrued liability	$ 0
Common stock issued in payment of accrued liability, shares	0
Stock warrants exercised, shares	0
Stock options exercised	$ 1,372					$ 1						1,371
Stock options exercised, shares	767,560					768,000
Restricted stock granted, shares	758,904					758,000
Restricted stock forfeited, shares											33,000
Treasury stock purchased	$ (6,345)										$ (6,345)
Treasury stock purchased, shares	473,304										473,000
Stock surrendered for exercise of stock options	$ (1,332)										$ (1,332)
Stock surrendered for exercise of stock options, shares	106,810										107,000
Excess tax benefit related to share-based awards	$ 1,273											1,273
Stock compensation expense	14,681											14,681
Investment in Flotek Gulf, LLC and Flotek Gulf Research, LLC	$ 7																		7
Stock issued in acquisition					$ 1,014											$ 1,014
Stock issued in acquisition, shares	60,024									60,000
Repurchase of common stock	$ (9,697)										$ (9,697)
Repurchase of common stock, shares											800,000
Retirement of Treasury Stock, shares	0
Ending balance at Dec. 31, 2015	$ 294,009					$ 6					$ (17,869)	$ 273,451					$ (1,237)	$ 39,300	$ 358
Ending balance, shares at Dec. 31, 2015						56,220,000					1,785,000